+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ovarian"

Ovarian Cancer Pipeline Analysis Report - Product Thumbnail Image

Ovarian Cancer Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
Contraceptive Pills Market Report and Forecast 2023-2031 - Product Thumbnail Image

Contraceptive Pills Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Female Infertility: Epidemiology Forecast to 2033 - Product Thumbnail Image

Female Infertility: Epidemiology Forecast to 2033

  • Report
  • June 2024
  • 38 Pages
  • Global
From
From
Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape - Product Thumbnail Image

Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape

  • Report
  • March 2024
  • 77 Pages
  • Global
From
Ovarian Cancer Opportunity Assessment and Forecast - Product Thumbnail Image

Ovarian Cancer Opportunity Assessment and Forecast

  • Report
  • February 2024
  • 79 Pages
  • Global
From
From
Loading Indicator

The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy. The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth. Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more